Printer Friendly

COPLEY PHARMACEUTICAL ANNOUNCES THE APPOINTMENT OF ANTHONY A. BONELLI, PRESIDENT AND CHIEF OPERATING OFFICER

 CANTON, Mass., May 20 /PRNewswire/ -- Copley Pharmaceutical, Inc. (NASDAQ-NMS: CPLY) today said its board of directors has announced the appointment of Anthony A. Bonelli, president and chief operating officer, effective May 24. He succeeds Jane C.I. Hirsh, who will continue her role as CEO and chairperson of the board. Bonelli brings to Copley his vast experience in the emerging and rapidly growing managed care market.
 Bonelli was most recently vice president of institutional health care for the Parke Davis division of the Warner-Lambert Company. At Warner-Lambert, Bonelli was responsible for the marketing and sales activities of the Warner-Lambert, Parke Davis and Warner Chilcott product lines in the institutional, government and managed health care market segments. Prior to joining Warner-Lambert in 1986, Bonelli was employed for 15 years by Schering-Plough Corporate where he held various sales and marketing positions.
 Bonelli is a member of Universal Standard Medical Laboratories, Inc. board of directors and the Chilton Medical Hospital Foundation board. He is an associate member of the American Society of Hospital Pharmacists, American Society of Consulting Pharmacists, American Academy of Managed Care Pharmacists, National Council of Prescription Drug Programs, and has served on various National Pharmaceutical Council and Pharmaceutical Manufacturers Association committees.
 Bonelli holds a JD in law from the University of San Francisco, an MBA in marketing/finance from Rutgers University, and an AB in biological sciences from Harvard University.
 Copley Pharmaceutical, Inc. is a leading manufacturer and marketer of a broad range of off-patent prescription and over-the-counter pharmaceuticals in a variety of dosages. The company markets its products to distributors, retail chains, wholesalers, hospitals, government agencies and managed care entities.
 -0- 5/20/93
 /CONTACT: Dr. Mark Hirsh, executive vice president-marketing and business development of Copley Pharmacueticals, 800-325-6111 or 617-821-6111/
 (CPLY)


CO: Copley Pharmaceutical Inc. ST: Massachusetts IN: SU:

DJ -- NE012 -- 0808 05/20/93 13:20 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:May 20, 1993
Words:309
Previous Article:PACKARD-HUGHES INTERCONNECT, NIPPON AVIONICS TO MARKET NEW TEST PROBE TECHNOLOGY IN JAPAN
Next Article:TIME WARNER INC. ELECTS FOUR NEW MEMBERS TO ITS BOARD OF DIRECTORS
Topics:


Related Articles
ICN AND SUBSIDIARY COMPANIES ANNOUNCE MANAGEMENT APPOINTMENTS
ROBERTS PHARMACEUTICAL CORPORATION ANNOUNCES APPOINTMENT OF CHIEF OPERATING OFFICER
ROBERTS PHARMACEUTICAL CORPORATION ANNOUNCES APPOINTMENT OF CHIEF OPERATING OFFICER
GLAXO INC. NAMES EXECUTIVES TO NEW POSITIONS
COPLEY PHARMACEUTICAL, INC. ANNOUNCES APPOINTMENT OF KENNETH LARSEN AS PRESIDENT; DEPARTURE OF ANTHONY BONELLI
COPLEY PHARMACEUTICAL, INC. NAMES GABRIEL R. CIPAU, PH.D., PRESIDENT, CEO AND BOARD MEMBER;
COPLEY PHARMACEUTICAL, INC. ANNOUNCES RESIGNATION OF CHIEF FINANCIAL OFFICER
NEUMAN DISTRIBUTORS, INC., NAMES ANTHONY BONELLI PRESIDENT & COO
COPLEY PHARMACEUTICAL, INC. APPOINTS EXECUTIVE VICE PRESIDENT, OPERATIONS
COPLEY PHARMACEUTICAL, INC. APPOINTS BARBARA SHERRILL AS CHIEF FINANCIAL OFFICER

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters